What is a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Below is a list of notable value stocks in the healthcare sector:
- National Healthcare NHC - P/E: 7.06
- Akouos AKUS - P/E: 0.43
- 9 Meters Biopharma NMTR - P/E: 7.24
- Repare Therapeutics RPTX - P/E: 7.59
- Collegium Pharmaceutical COLL - P/E: 7.01
This quarter, National Healthcare experienced a decrease in earnings per share, which was 0.98 in Q2 and is now 0.96. The company's most recent dividend yield sits at 3.05%, which has increased by 0.33% from 2.72% last quarter.
Akouos has reported Q2 earnings per share at -0.66, which has decreased by 40.43% compared to Q1, which was -0.47. Akouos does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
9 Meters Biopharma looks to be undervalued. It possesses an EPS of -0.03, which has not changed since last quarter (Q1). 9 Meters Biopharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Repare Therapeutics's earnings per share for Q2 sits at -0.71, whereas in Q1, they were at -0.58. Repare Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
This quarter, Collegium Pharmaceutical experienced a decrease in earnings per share, which was 0.27 in Q2 and is now 0.22. Collegium Pharmaceutical does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.